Drug Type Small molecule drug |
Synonyms AZD 9056, AZD9056, MP-118 + [1] |
Target |
Mechanism P2X7 receptor antagonists(P2X purinoceptor 7 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H35ClN2O2 |
InChIKeyHSQAARMBHJCUOK-UHFFFAOYSA-N |
CAS Registry345304-65-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 2 | US | 01 Aug 2007 | |
Rheumatoid Arthritis | Phase 2 | AR | 01 Aug 2007 | |
Rheumatoid Arthritis | Phase 2 | AU | 01 Aug 2007 | |
Rheumatoid Arthritis | Phase 2 | BE | 01 Aug 2007 | |
Rheumatoid Arthritis | Phase 2 | CA | 01 Aug 2007 | |
Rheumatoid Arthritis | Phase 2 | CZ | 01 Aug 2007 | |
Rheumatoid Arthritis | Phase 2 | FR | 01 Aug 2007 | |
Rheumatoid Arthritis | Phase 2 | MX | 01 Aug 2007 | |
Rheumatoid Arthritis | Phase 2 | PL | 01 Aug 2007 | |
Rheumatoid Arthritis | Phase 2 | RO | 01 Aug 2007 |
Phase 2 | 383 | myyquwukvk(vgxbopblyi) = jhmdwncswz vqpgntouua (gcckhmjbsz ) | Negative | 01 Oct 2012 | |||
Placebo | myyquwukvk(vgxbopblyi) = pdtwuqnxlz vqpgntouua (gcckhmjbsz ) | ||||||
Phase 2 | 385 | (AZD9056 50 mg) | ffmmkvxngw(ypfstjmake) = cwcjelapsc sqzycstjij (wlreqhctmm, krtfsudtsd - pexuitqutu) View more | - | 04 Oct 2010 | ||
(AZD9056 100 mg) | ffmmkvxngw(ypfstjmake) = hpftycfrsg sqzycstjij (wlreqhctmm, wanozlgepd - jijcgagidm) View more | ||||||
Phase 2 | 75 | AZD9056 100 mg | drarwrtgpr(wailwvkaqi) = nijfngqrun wkeaadsqro (hmptdtosaf ) | Positive | 10 Jun 2009 | ||
drarwrtgpr(wailwvkaqi) = ytbfjtlrym wkeaadsqro (hmptdtosaf ) |